Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)
- Conditions
- Open Angle Glaucoma
- Registration Number
- NCT01788319
- Lead Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Brief Summary
This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment strategy for glaucoma patients. It is done with a laser device that can also be used for many other ophthalmic applications, thus reducing the economic burden of treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- individuals over 18 years old
- willing to sign an informed consent and able to comply the requirements of the study
- having no other ocular diseases besides glaucoma
- history of ocular trauma
- intraocular surgery (except for phaco)
- pigment dispersion and exfoliation glaucoma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method to compare the intraocular pressure reduction with the micropulse laser trabeculoplasty (532nm) versus the conventional laser trabeculoplasty (532nm) one year of follow-up
- Secondary Outcome Measures
Name Time Method Secondary the complication rate between the two techniques will be compared one year of follow up
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Department of Ophthalmology, UZLeuven
🇧🇪Leuven, Belgium
Department of Ophthalmology, UZLeuven🇧🇪Leuven, Belgium